Early-phase trial data for a theranostic radiopharmaceutical, 177Lu-NeoB, demonstrate safety and potential tumour control in patients with GRPR-positive …
Early-phase trial data for a theranostic radiopharmaceutical, 177Lu-NeoB, demonstrate safety and potential tumour control in patients with GRPR-positive …
The European Commission launched several new funding opportunities under its Horizon Europe “Health” cluster to boost innovation in …
A new configuration of the I-SPY Platform, named I-SPY2.2, introduces sequential multiple-assignment randomization to improve matching of therapy …
FDA’s Oncologic Drugs Advisory Committee (ODAC) critiques a major lymphoma trial for having too few U.S. participants, warning …
Novavax’s protein-based COVID-19 vaccine, Nuvaxovid, wins FDA approval for older adults and people with underlying health risks under …
Phase III SEQUOIA-HCM analyses show aficamten offers benefit to patients with varying symptom severity and across regions, opening …
Researchers propose a new framework that combines domestic real-world data with overseas trial data to make global clinical …
In May 2025, a gene therapy for Rett syndrome has cleared major regulatory design review and is activating …
New oral vaccine succeeds against multiple cholera strains offering promise for broad use in endemic regions
New antibody therapeutic enters Phase 1 with hopes of helping women with hot flashes and night sweats